XML 38 R49.htm IDEA: XBRL DOCUMENT v3.19.3
DEBT (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 12, 2018
May 12, 2017
May 05, 2017
Apr. 10, 2017
Mar. 16, 2017
Aug. 04, 2016
Jun. 24, 2019
May 28, 2019
Oct. 17, 2018
May 31, 2018
Mar. 23, 2017
Mar. 20, 2017
Nov. 16, 2015
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 20, 2018
Dec. 31, 2017
Dec. 31, 2018
Mar. 31, 2018
Nov. 16, 2017
Jul. 31, 2017
Jan. 31, 2017
Dec. 31, 2016
Nov. 30, 2016
Oct. 31, 2016
Sep. 30, 2016
Sep. 13, 2016
Convertible notes payable, principal amount                           $ 2,919,286   $ 2,919,286                          
Debt outstanding amount                           2,469,303   2,469,303       $ 1,514,583                  
Debt discount                           3,169,672   3,169,672       3,350,000                  
Amortization of debt discount                               284,008 $ 2,834,620                        
Accured interest expense                           (366,611) $ (156,362) (955,593) $ (715,359)                        
TFF [Member]                                                          
Short term debt borrowing capacity                           $ 15,000,000   $ 15,000,000                          
Libor rate description                               (i) all lending in U.S. dollars is the one-month LIBOR plus six (6%) percent margin; and (ii) for all lending in Euro, the one-month Euribor Rate plus six (6%) percent per annum, commencing June 1, 2018                          
CEO [Member]                                                          
Percentage of wholly-owned subsidiary shares                           51.00%   51.00%                          
Trade Facility Agreements [Member]                                                          
Debt outstanding amount                                         $ 5,866,910                
Payment of interest and principal                   $ 1,123,600                                      
Synthesis facility agreement [Member] | TFF [Member]                                                          
Debt outstanding amount                 $ 5,629,555                                        
Accrued interest                 $ 524,094                                        
Description for amendment to agreement under ASU 470-50                 The Company evaluated the amended agreement under ASC 470-50 and concluded that it did not meet the 10% cash flow test and recorded debt modification expense of $138,110                                        
Debt modification expense                 $ 138,110                                        
Synthesis facility agreement [Member] | TFF [Member] | Principal balance 1 [Member]                                                          
Maturity date                 Aug. 31, 2021                                        
Accrued interest                           $ 8,242   $ 8,242       0                  
Debt split, balance                 $ 2,000,000         181,000   181,000       2,291,200                  
Interest rate description                 6% per annum plus one-month Euribor, when it is positive, on the Euro balance                                        
Repayment of debt, periodic payments                 $ 125,000                                        
Frequency of periodic payments                 Quarterly                                        
Synthesis facility agreement [Member] | TFF [Member] | Principal balance 2 [Member]                                                          
Maturity date                 Aug. 31, 2021                                        
Accrued interest                           14,201   14,201       19,834                  
Debt split, balance                 $ 4,000,000         4,000,000   4,000,000       4,000,000                  
Interest rate description                 6% per annum plus one month Libor on the USD balance                                        
Repayment of debt, periodic payments                 $ 150,000                                        
Frequency of periodic payments                 Quarterly                                        
Loan facility agreement [Member]                                                          
Debt discount                           191,034   191,034                          
Unamortized debt discount                           20,237   $ 20,237                          
Marathon [Member]                                                          
Shares issued for settlement of debt                               546,298                          
Distribution and equity acquisition agreement, description                               As consideration for its services, Company received: (a) a 33 1/3% equity interest or 5 million shares in Marathon as partial consideration for the Company’s distribution services; and (b) received cash of CAD $2,000,000, subject to repayment in Common Shares of the Company if it fails to meet certain performance milestones. The Company is entitled to receive an additional CAD $2,750,000 upon the Company’s receipt of gross sales of CAD $6,500,000 and an additional CAD $2,750,000 upon receipt of gross sales of CAD $13,000,000.                          
Settlement amount                           1,554,590   $ 1,554,590                          
Cash received                               $ 2,000,000                          
Grigorios Siokas [Member]                                                          
Interest rate                                   4.70%                      
Interest rate             750.00% 750.00%               750.00%                          
Shares issued for settlement of debt             73,334 66,667               140,001                          
Grigorios Siokas [Member] | Loan facility agreement [Member] | Synthesis facility agreement [Member]                                                          
Common stock shares issuable upon conversion of debt/convertible securities           10,000,000                                              
DOC Pharma S.A. [Member] | Loan agreement [Member]                                                          
Debt outstanding amount                           13,086   $ 13,086                          
Accrued interest                           1,034   1,034                          
SkyPharm [Member] | MediHelm S.A. [Member]                                                          
Amortization of debt discount                               66,227     $ 69,269                    
Origination fees                               137,063                          
SkyPharm [Member] | Trade Facility Agreements [Member]                                                          
Debt outstanding amount                   $ 5,369,678                                      
Short term debt borrowing capacity   $ 181,000                                                      
Description for the repayment   The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables.                                                      
Term of credit facility   12 months                                                      
Credit facility origination fee, percentage   2.00%                                                      
Monthly credit fee, percentage   1.00%                                                      
Proceeds from debt $ 247,117                                                        
SkyPharm [Member] | Trade Facility Agreements [Member] | Minimum [Member]                                                          
Short term debt borrowing capacity                                           $ 2,291,200              
SkyPharm [Member] | Trade Facility Agreements [Member] | Maximum [Member]                                                          
Short term debt borrowing capacity                                           $ 6,873,600              
SkyPharm [Member] | Loan facility agreement [Member]                                                          
Interest rate           10.00%                                              
Short term debt borrowing capacity           $ 1,292,769                                              
Description for the repayment           The amounts owed under the Loan Facility were repayable upon the earlier of (i) three months following the demand of the lender; or (ii) August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility                                              
SkyPharm [Member] | Amendment to loan facility agreement [Member]                                                          
Debt outstanding amount                                                         $ 240,251
Short term debt borrowing capacity                                                         $ 1,533,020
SkyPharm [Member] | Second amendment to loan facility agreement [Member]                                                          
Debt outstanding amount                                     3,117,287                    
Debt discount                                     42,149           $ 126,624        
Maturity date                     Aug. 04, 2016                                    
Interest rate                     10.00%                                    
Accrued interest                                     221,657                    
Short term debt borrowing capacity                     $ 2,664,960               $ 70,000       $ 382,327 $ 155,516 $ 452,471 $ 250,000 $ 100,000 $ 174,000  
Description for the repayment                     The amounts owed under the Loan Facility shall be repayable upon the earlier of (i) seventy five days following the demand of the Lender; or (ii) August 31, 2018                                    
Common stock shares issuable upon conversion of debt/convertible securities                     1,000,000                                    
SkyPharm [Member] | Bridge Loans [Member]                                                          
Debt outstanding amount         $ 50,000             $ 106,542   97,700   97,700                          
Maturity date     Sep. 30, 2017   Apr. 16, 2017             Apr. 20, 2017                                  
Interest rate     10.00%   10.00%             10.00%                                  
Accrued interest         $ 14,138             $ 16,857   25,082   25,082                          
Short term debt borrowing capacity     $ 34,745   $ 50,000             $ 120,220   50,000   50,000                          
Amended maturity date         May 16, 2017             May 20, 2017                                  
Gain on debt settlement                       $ 19,695                                  
Additional gain on settlement of debt                       4,668                                  
Loan fixed payoff amount                       $ 106,542                                  
SkyPharm [Member] | Decahedron [Member] | Trade Facility Agreements [Member]                                                          
Short term debt borrowing capacity       $ 2,998,875                                                  
Description for the repayment       The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables                                                  
Term of credit facility       12 months                                                  
Credit facility origination fee, percentage       2.00%                                                  
Monthly credit fee, percentage       1.00%                                                  
Panagiotis Drakopoulos [Member] | Loan agreement [Member]                                                          
Debt outstanding amount                           14,177   14,177       14,893                  
Maturity date                         Nov. 15, 2016                                
Interest rate                         6.00%                                
Accrued interest                           4,328   $ 4,328       3,538                  
Short term debt borrowing capacity                         $ 42,832                                
On November 1, 2015 [Member] | DOC Pharma S.A. [Member] | Loan agreement [Member]                                                          
Interest rate                               2.00%                          
On April 18, 2018 [Member]                                                          
Debt outstanding amount                           3,078,442   $ 3,078,442       3,078,442                  
Maturity date                               Dec. 31, 2021                          
Accrued interest                           563,582   $ 563,582       414,830                  
Gain on debt settlement                               $ 23,354                          
Libor rate description                               Additionally the interest rate was amended such that the interest rate for all advances is 4% plus the 3-Month Libor rate                          
May 5 2017 [Member] | SkyPharm [Member] | Bridge Loans [Member]                                                          
Debt outstanding amount                           34,745   $ 34,745       34,745                  
Accrued interest                           5,043   5,043       $ 3,906                  
Loan Facility July 6, 2017 [Member]                                                          
Fees forgiven related to advance                               40,000                          
Senior Promissory Notes [Member] | Unaffiliated Third Party [Member] | April 1, 2019 [Member]                                                          
Convertible notes payable, principal amount                           250,000   250,000                          
Debt outstanding amount                           250,000   $ 250,000                          
Maturity date                               Apr. 01, 2020                          
Repayment of debt description                               The Company may prepay the Notes within the first six (6) months by payment of unpaid interest for the first six (6) months interest and after six (6) months, with a (2%) percent ($5,000) premium on each note.                          
Interest rate                               15.00%                          
Accrued interest                           0   $ 0                          
Senior Promissory Notes [Member] | Unaffiliated Third Party [Member] | April 3, 2019 [Member]                                                          
Convertible notes payable, principal amount                           250,000   250,000                          
Debt outstanding amount                           250,000   $ 250,000                          
Maturity date                               Apr. 03, 2020                          
Repayment of debt description                               The Company may prepay the Notes within the first six (6) months by payment of unpaid interest for the first six (6) months interest and after six (6) months, with a (2%) percent ($5,000) premium on each note.                          
Interest rate                               15.00%                          
Accrued interest                           18,646   $ 18,646                          
Senior Promissory Notes [Member] | Unaffiliated Third Party [Member] | April 9, 2019 [Member]                                                          
Convertible notes payable, principal amount                           250,000   250,000                          
Debt outstanding amount                           250,000   $ 250,000                          
Maturity date                               Apr. 09, 2020                          
Repayment of debt description                               The Company may prepay the Note within the first six (6) months by payment of unpaid interest for the first six (6) months and after six (6) months, with a two (2%) percent ($5,000) premium.                          
Interest rate                               15.00%                          
Accrued interest                           17,979   $ 17,979                          
Due from related party                           500,000   500,000                          
Senior Promissory Notes [Member] | August 1, 2019 [Member]                                                          
Convertible notes payable, principal amount                           500,000   $ 500,000                          
Maturity date                               Aug. 01, 2020                          
Accrued interest                           12,534   $ 12,534                          
Loans payable                           1,500,000   $ 1,500,000                          
Description for the payment of installments                               The Company may prepay the August Note within the first six (6) months by payment of unpaid interest for the first six (6) months and, after six (6) months, with a two (2%) percent ($10,000) premium.                          
Interest rate                               15.00%                          
Subsequent Event [Member] | Senior Promissory Notes [Member] | July 24, 2019 [Member]                                                          
Convertible notes payable, principal amount                           750,000   $ 750,000                          
Maturity date                               Jul. 24, 2020                          
Accured interest expense                               $ 21,268                          
Due to related party                           $ 750,000   $ 750,000